Namzaric Titration Pack

RxCUI: 1858971
RxNorm name: Namzaric Titration Pack
Display name: Namzaric Titration Pack
Full name: Namzaric Titration Pack
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Namzaric	MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE	Allergan, Inc.	90fedc32-19e5-480c-afc6-f35a5cf4b9aa	2026-03-06	Warnings, Adverse reactions	Exact identifier rxcui: 1858971

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
90fedc32-19e5-480c-afc6-f35a5cf4b9aa	{7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule [Namzaric]) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 21 MG Extended Release Oral Capsule [Namzaric]) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 28 MG Extended Release Oral Capsule [Namzaric]) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 7 MG Extended Release Oral Capsule [Namzaric]) } Pack [Namzaric Titration Pack] [BPCK] · Namzaric Titration Pack [PSN] · Namzaric Titration Pack [SY]	3	23	These highlights do not include all the information needed to use NAMZARIC capsules safely and effectively. See full prescribing information for NAMZARIC capsules. NAMZARIC (memantine and donepezil hydrochlorides) extended-release capsules, for oral use Initial U.S. Approval: 2014	20260306